Therefore, the expressions ofHBEGF and AKT2, as target genes ofHsa-miR-11181-5p, and TGFΒR1, as the target gene ofHsa-miR-11181-3p, were measured in brain tumour samples such as GBM andhigh-grade meningioma (grade IV). The gene discussed is AKT2; the disease is glioblastoma.